Cargando…

PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK

Background: In addition to protein tyrosine kinases, accumulating evidence has shown that protein tyrosine phosphatases (PTPs) are suitable therapeutic targets in cancer. PRL-3 is a PTP member that has been well studied in many malignant tumours. The goal of the present study was to elucidate the ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiming, Zhou, Qianlei, Liu, Qinghua, He, Zhanghai, Yan, Yongcong, Lin, Jianhong, Chen, Zheng, He, Chuanchao, Mao, Kai, Wang, Jie, Zhou, Zhenyu, Xiao, Zhiyu, Zhang, Jianlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481414/ https://www.ncbi.nlm.nih.gov/pubmed/32929353 http://dx.doi.org/10.7150/thno.42069

Ejemplares similares

Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression
por: Yan, Yongcong, et al.
Publicado: (2020)

INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma
por: Zhou, Qianlei, et al.
Publicado: (2022)

Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study
por: Xiao, Zhiyu, et al.
Publicado: (2019)

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019)

Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis
por: Liu, Haohan, et al.
Publicado: (2022)

Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma
por: Liu, Haohan, et al.
Publicado: (2020)

A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways
por: Chen, Zheng, et al.
Publicado: (2019)

A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer
por: Yan, Yongcong, et al.
Publicado: (2020)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence
por: He, Chuanchao, et al.
Publicado: (2017)

Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway
por: Zhou, Qiming, et al.
Publicado: (2018)

ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
por: Zhou, Zhenyu, et al.
Publicado: (2019)

Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma
por: Yan, Yongcong, et al.
Publicado: (2019)

A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma
por: Xu, Qiaodong, et al.
Publicado: (2018)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Depletion of Tissue-Specific Ion Transporters Causes Differential Expression of PRL Targets in Response to Increased Levels of Endogenous PRL
por: Shu, Tingting, et al.
Publicado: (2018)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study
por: Mao, Kai, et al.
Publicado: (2018)

Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis
por: Bai, Yunpeng, et al.
Publicado: (2016)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
por: Jin, Shaowen, et al.
Publicado: (2014)

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

PRL-3 activates mTORC1 in Cancer Progression
por: Ye, Zu, et al.
Publicado: (2015)

Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
por: Fiordalisi, James J., et al.
Publicado: (2013)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Generation of conditional knockout alleles for PRL-3()
por: Yan, Hong, et al.
Publicado: (2011)

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
por: Loh, Amos Hong Pheng, et al.
Publicado: (2023)

Effect of Disease Progression on the PRL Location in Patients With Bilateral Central Vision Loss
por: Tarita-Nistor, Luminita, et al.
Publicado: (2020)

lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway
por: Luo, Tianping, et al.
Publicado: (2020)

Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL
por: Alam, Zohaib, et al.
Publicado: (2015)

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
por: Rubio, Teresa, et al.
Publicado: (2016)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)

Binocularity Principles of PRL Development in Patients With Macular Disease
por: Tarita-Nistor, Luminita, et al.
Publicado: (2022)

Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma
por: Jin, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_es1b32an0mcotofp3akt1s1e4p